Intrinsic Imaging is the world leader assessing the clinical performance of medical devices using artificial intelligence, deep learning and computer assisted detection algorithms.
Bolton, MA, San Antonio, TX, October 18, 2017
Intrinsic Imaging, a full-service medical imaging core lab providing comprehensive services in support of clinical trials for new drug applications and medical devices, announces today it was selected by an emerging artificial intelligence (AI) company to conduct its pivotal medical device clinical trial. Throughout this trial, Intrinsic Imaging will assess the clinical performance of this novel AI software in screening clinical images.
Intrinsic Imaging has established itself as the world leader in conducting multi-reader multi-case (MRMC) trials to assess the clinical performance of medical devices using artificial intelligence (AI), deep learning (DL) and computer assisted detection (CAD) algorithms. This is Intrinsic Imaging’s twelfth AI/DL/CAD MRMC clinical trial award in support of an FDA/EMEA submission.
For this study, Intrinsic Imaging was selected due to its:
- Proven success with multiple FDA clearances of Class I-III AI/DL/CAD software
- Operational excellence and experience conducting large MRMC AI/DL/CAD trials
- Successful FDA Inspection of an MRMC AI/DL/CAD trial with Zero 483 observations
- ISO 13485 certification specifically for providing services for medical devices
- Ability to quickly source large numbers of reviewers using its network of 200+ reviewers
- Ability to effectively and efficiently manage 6,000-20,000 case reviews
“Certified by the British Standards Institute, Intrinsic Imaging provides the most efficient means to assess the clinical performance of AI/DL/CAD software in support of an FDA and EMEA submission.” said Todd A. Joron, BSc. MBA, President & COO, Intrinsic Imaging.
To have Intrinsic Imaging manage your AI/DL/CAD medical device clinical trial, please contact Intrinsic Imaging at [email protected] or call 1-978-634-2215.
About Intrinsic Imaging, LLC
Intrinsic Imaging is a full-service medical imaging core lab providing comprehensive services in support of Phase I-IV clinical trials and Class I, II, III medical device trials. Our team consists of more than 70 full-time, board-certified, fellowship-trained radiologists and 100 consulting radiologists and key opinion leaders. Our team has sub-specialization in all therapeutic areas including Cardiovascular, Metabolic & Pulmonary, Gastrointestinal & Genitourinary, Medical Device, Musculoskeletal, Neuroradiology and Oncology. With our medical expertise, operational excellence and scalable technology, Intrinsic Imaging is ideally positioned to provide unprecedented imaging core lab services around the world.